View This Report »
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...
According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...
The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the ...